Eagle's Eye View: Your Weekly CV Update From ACC.org

Discover groundbreaking strategies for diagnosing and managing myocarditis, highlighting its often asymptomatic presentation and the diagnostic power of cardiac MRI. Dive into intriguing sex-based differences in outcomes between PCI and CABG from recent trials. Finally, explore effective long-term management techniques for right ventricular outflow tract dysfunction in those who've had repaired tetralogy of Fallot. Each topic opens up essential conversations about patient care and tailored approaches in cardiology.

Discover how waist-high compression tights can aid patients with postural orthostatic tachycardia syndrome (POTS). Learn about the role of genetic testing in personalizing platelet function during coronary interventions. Explore the debate on continuing aspirin therapy for patients with drug-eluting stents undergoing non-cardiac surgeries, uncovering potential safety benefits in halting the medication. These insights are crucial for enhancing cardiovascular care.

The discussion uncovers the alarming rise of obesity trends among all age groups in the U.S., with projections into 2050. It also presents critical guidelines on CPR, emphasizing the importance of AEDs in emergencies. Additionally, there's an insightful analysis of the risks associated with using NSAIDs while on anticoagulants, particularly for those with a history of venous thromboembolism. The exploration of these health topics adds depth to the ongoing conversation about improving community health and safety.

Discover groundbreaking research from recent AHA sessions, like the BROAD trial focused on blood pressure control. Learn how tirzepatide from the SUMMIT study holds promise for obesity-related heart issues. The OPTION trial compares new stroke prevention methods in atrial fibrillation. Explore dual trials from CLEAR SYNERGY on spironolactone and colchicine for heart attack patients. Finally, hear about innovative uses for refurbished pacemakers in Project My Heart Your Heart.

Discover the surprising benefits of moderate-intensity exercise for patients with hypertrophic cardiomyopathy. Learn the critical signs and treatment strategies for Kawasaki Disease, a key cause of heart issues in children. Dive into groundbreaking research on how self-reported race and social determinants influence coronary heart disease risk, based on a study involving over 240,000 participants. This engaging discussion connects genetics, race, and socio-economic factors in understanding heart health outcomes.

Discover the latest advancements in transseptal mitral valve-in-valve procedures, showcasing impressive outcomes from recent studies. Dive into the debate over complete versus culprit-only revascularization methods for older patients facing myocardial infarction. Plus, explore the intriguing connections between hypertensive pregnancy and heightened risks of coronary artery disease in women. This insightful discussion brings together cutting-edge cardiovascular research and important implications for patient care.

Discover the latest on TAVR's surprising outcomes in younger patients with comorbidities. Delve into the showdown between atorvastatin and rosuvastatin, revealing potential advantages for cardiovascular health. Finally, learn about a large trial that looked at how cutting down sedentary time might impact blood pressure in desk workers but found no significant changes. Tune in for intriguing insights from the world of cardiovascular health!

This week, the discussion centers around groundbreaking clinical trials from the recent TCT conference. The EARLY TAVR trial compares TAVR options versus clinical surveillance for aortic stenosis. Insights into the TRISCEND II trial reveal innovations for treating severe tricuspid regurgitation. The ECLIPSE study examines the benefits of orbital atherectomy before PCI. Finally, the CLEAR SYNERGY trial investigates colchicine effects post-PCI for STEMI patients. These trials are set to reshape cardiovascular treatment approaches.

In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart failure and reduced ejection fraction (HFrEF). He then explores the effect of race and sacubitril/valsartan use in HF patients documented in a pooled analysis of the PARADIGM-HF and PARAGON-HF trials. Finally, Dr. Eagle discusses the utility of systolic blood pressure (BP) polygenic risk scores and the treatment response in people with hypertension.    Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at anthracycline cardiotoxicity in treatment of cancer patients. He then explores a scientific statement from the American Heart Association on cardiac arrhythmias and autonomic dysfunction associated with COVID-19. Finally, Dr. Eagle discusses the SWEDEHEART registry and intensive early and sustained lowering of non–HDL cholesterol after MI and prognosis.    Subscribe to Eagle’s Eye View